Inactivation of p27Kip1 promotes chemical mouse liver tumorigenesis in the resistant strain C57BL/6J

Molecular Carcinogenesis

Volumn 47, Issue 1, 2008, Pages 47-55

  Sun, Daqian ^a   Ren, Hao ^a,b   Oertel, Michael ^a   Sellers, Rani S ^a   Shafritz, David A ^a   Zhu, Liang ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cdk; Chemical carcinogenesis; Cyclin E; DEN; Liver tumor; p27Kip1

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DIETHYLNITROSAMINE; GLUCOSE 6 PHOSPHATASE; PHENOBARBITAL; CDKN1B PROTEIN, MOUSE; PRIMER DNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; C57BL 6 MOUSE; CANCER INHIBITION; CANCER MODEL; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENOTYPE; HISTOPATHOLOGY; KNOCKOUT MOUSE; LIVER ADENOMA; LIVER CARCINOGENESIS; LIVER CELL; LIVER TUMOR; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; TISSUE SECTION; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; IMMUNOHISTOCHEMISTRY; KINETICS; METABOLISM; MOUSE MUTANT; PATHOLOGY; POLYMERASE CHAIN REACTION;

MUS;

ANIMALS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DISEASE MODELS, ANIMAL; DNA PRIMERS; GLUCOSE-6-PHOSPHATASE; IMMUNOHISTOCHEMISTRY; KINETICS; LIVER NEOPLASMS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENOTYPE; POLYMERASE CHAIN REACTION;

EID: 38349049158     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20360     Document Type: Article

References (21)

1. Fera ML, Rivkin M, Tasch M, et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorignesis, and female sterility in p27Kip1-deficient mice. Cell 1996;85:733-744.
2. Nakayama K, Ishida N, Shirane M, et al. Mice lacking p27Kip1 display incresased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996;85:707-720.
3. Kiyokawa H, Kineman RD, Manova-Todorova K, et al. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27Kip1. Cell 1996;85:721-732.
4. King TJ, Gurley KE, Prunty J, et al. Deficiency in the gap junction protein connexin32 alters p27Kip1 tumor suppression and MAPK activation in a tissue-specific manner. Oncogene 2005;24:1718-1726.
5. Fero ML, Randel E, Gurley KE, Roberts JM, Kemp CJ. The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature 1998;396:177-180.
6. Diwan BA, Rice JM, Ohshima M, Ward JM. Interstrain differences in susceptibility to liver carcinogenesis initiated by N-nitrosodiethylamine and its promotion by phenobarbital in C57BL/6NCr, C3H/HeNCrMTV- and DBA/2NCr mice. Carcinogenesis 1986;7:215-220.
7. Drinkwater NR, Ginsler JJ. Genetic control of hepatocarcinogenesis in C57BL/6J and C3H/HeJ inbred mice. Carcinogenesis 1986;7:1701-1707.
8. Verna L, Whysner J, Williams GM. N-nitrosodiethylamine mechanistic data and risk assessment: Bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol Ther 1996;71:57-81.
9. Sarma DS, Rao PM, Rajalakshmi S. Liver tumor promotion by chemicals: Models and mechanisms. Cancer Surv 1986;5:781-798.
10. Moore MR, Drinkwater NR, Miller EC, Miller JA, Pitot HC. Quantitative analysis of the time-dependent development of glucose-6-phosphatase-deficient foci in the livers of mice treated neonatally with diethylnitrosamine. Cancer Res 1981;41:1585-1593.
11. Vesselinovitch SD, Mihailovich N. Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse. Cancer Res 1983;43:4253-4259.
12. Hanigan MH, Kemp CJ, Ginsler JJ, Drinkwater NR. Rapid growth of preneoplastic lesions in hepatocarcinogen-sensitive C3H/HeJ male mice relative to C57BL/6J male mice. Carcinogenesis 1988;9:885-890.
13. Chien WM, Rabin S, Macias E, et al. Genetic mosaics reveal both cell-autonomous and cell-nonautonomous function of murine p27Kip1. Proc Natl Acad Sci (USA) 2006;103:4122-4127.
14. Aleem E, Kiyokawa H, Kaldis P. Cdc2-cyclin E complexes regulate the G1/S phase transition. Nat Cell Biol 2005;7:831-836.
15. Martin A, Odajima J, Hunt SL, et al. Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1). Cancer Cell 2005;7:591-598.
16. Shaffer DR, Viale A, Ishiwata R, et al. Evidence for a p27 tumor suppressive function independent of its role regulating cell proliferation in the prostate. Proc Natl Acad Sci (USA) 2005;102:210-215.
17. Hanigan MH, Winkler ML, Drinkwater NR. Partial hepatectomy is a promoter of hepatocarcinogenesis in C57BL/6J male mice but not in C3H/HeJ male mice. Carcinogenesis 1990;11:589-594.
18. Karnezis AN, Dorokhov M, Grompe M, Zhu L. Loss of p27(Kip1) enhances the transplantation efficiency of hepatocytes transferred into diseased livers. J Clin Invest 2001;108:383-390.
19. Yuan RH, Ogawa A, Ogawa E, et al. p27Kip1 inactivation provides a proliferative advantage to transplanted hepatocytes in DPPIV/Rag2 double knockout mice after repeated host liver injury. Cell Transplant 2003;12:907-919.
20. Luedde T, Rodriguez ME, Tacke F, et al. p18(INK4c) collaborates with other CDK-inhibitory proteins in the regenerating liver. Hepatology 2003;37:833-841.
21. Bilger A, Bennett LM, Carabeo RA, et al. A potent modifier of liver cancer risk on distal mouse chromosome 1: Linkage analysis and characterization of congenic lines. Genetics 2004;167. 859-866.